Galbot closes $153 million round to scale G1 semi-humanoid robot for retail and logistics automation
The announcement
Chinese robotics developer Galaxy General Robot Co., operating under the brand name Galbot, has concluded a new financing round that brings in RMB 1.1 billion, equivalent to roughly $153 million. The company confirmed that this latest injection of capital pushes its cumulative funding over the past two years to approximately $335 million. The announcement was made public during the week of the transaction's completion, though the exact day of the closure was not specified in the available information. Given the reporting context, the round is understood to have closed in mid-2025, with the most precise date available being the month of July 2025.
The funding round was led by two principal investors: CATL, the battery manufacturing giant, and Puquan Capital, an investment firm. Additional participation came from a roster of institutional backers, including the China Development Bank, the China Development Bank Science and Technology Innovation Fund, the Beijing Robot Industry Fund, and Qiming Venture Partners, among others. The specific amounts contributed by each investor were not disclosed in the source material, nor were the valuation figures or equity stakes exchanged as part of the transaction. What is known is that CATL served as the core strategic investor in this round, a designation that signals a deeper relationship than a purely financial one.
According to the source material, the partnership between Galbot and CATL extends beyond capital. The two companies have stated their intention to collaborate on developing applications for Galbot's general embodied intelligence large model. This collaboration is aimed at promoting the adoption of that model across various use cases, though the source does not specify which industries or environments will be prioritized first. The strategic nature of CATL's involvement suggests that the battery manufacturer sees value in Galbot's artificial intelligence capabilities beyond the immediate product line, but the details of any joint product roadmap remain undisclosed.
The company's growth trajectory has been notable. From its origins as a single-person operation in 2016, Galbot has expanded to a workforce exceeding 1,000 employees. This figure was cited by Wang Xingxing, founder and CEO of Unitree Robotics, during the 2025 Summer Davos Forum held in Tianjin, China. It is worth noting that Wang's remarks were made in a public forum context and reflect the scale of Galbot's operations as of that event. The source does not clarify whether this headcount includes contract workers, temporary staff, or only full-time employees, nor does it break down the distribution between research, engineering, manufacturing, and administrative roles.
The funding announcement comes at a time when investor interest in embodied artificial intelligence and mobile manipulation robots is intensifying across the global robotics sector. The source material also references a separate development involving Unitree Robotics, which reportedly raised an unspecified amount of Series C funding at a valuation of approximately 12 billion yuan, or $1.7 billion. That information is provided as context for the broader market environment rather than as a direct comparison to Galbot's financial position.
Product and availability details
The primary use of the new capital, according to the company, is to commercialize its G1 semi-humanoid robot. The G1 was first released by Galbot in March 2025, making it a relatively recent addition to the company's product portfolio. The robot is classified as a semi-humanoid mobile manipulator, a category that distinguishes it from full humanoid robots. Instead of legs, the G1 is equipped with wheels, and it features two arms designed for manipulation tasks. This configuration is intended to provide mobility and dexterity while potentially reducing some of the complexity and cost associated with bipedal locomotion.
The G1's design is oriented toward operational tasks commonly found in retail, logistics, and warehousing environments. Specifically, the source material identifies four core functions that the robot is designed to automate: inventory management, replenishment, delivery, and packaging. These tasks are typically repetitive, labor-intensive, and often require a combination of navigation, object recognition, and precise handling. The robot's wheeled base allows it to move through facilities, while its two arms enable it to grasp, move, and manipulate items.
One of the key technical claims made by Galbot regarding the G1 is its ability to handle a wide variety of goods. The company states that its artificial intelligence models enable the robot to work with 5,000 different types of products. This figure is significant because it suggests a high degree of generalization in the robot's perception and manipulation capabilities. Rather than being limited to a narrow set of standardized items, the G1 is purportedly capable of recognizing and interacting with a diverse range of objects, which could include different shapes, sizes, weights, and packaging materials. The source does not specify how this capability is measured, whether it refers to distinct SKUs, product categories, or physical object types, nor does it provide details on the underlying AI architecture beyond the general reference to advanced models.
The company has demonstrated the G1 working autonomously in a pharmacy setting, according to the source material. This demonstration, which was showcased publicly, illustrates the robot's ability to operate in environments that are not purpose-built for automation. Pharmacies typically involve small, varied items, shelving, and the need for careful handling, making them a challenging test case for a mobile manipulator. The fact that Galbot chose a pharmacy as a demonstration environment suggests that the company is targeting use cases beyond large-scale distribution centers, potentially including smaller retail outlets, healthcare facilities, and other customer-facing or back-of-house operations.
Regarding availability, the source material does not provide specific information on when the G1 will be commercially available, in which geographic markets it will be sold, or at what price point. The company's stated goal is to use the new funding to commercialize the robot, which implies that the product is either in a late-stage pilot phase or early production, but the exact commercial launch timeline has not been disclosed. Similarly, there is no information on production volumes, manufacturing partners, or lead times for orders. The source also does not mention any service-level agreements, response times, or spare-part availability commitments, and none should be inferred from the available information.
It is also unclear whether the G1 is currently deployed with any customers in a production capacity or if all deployments to date are demonstrations and pilots. The pharmacy demonstration suggests at least one operational environment, but the source does not name any commercial customers or provide case studies with measurable outcomes such as throughput improvements, error rate reductions, or return on investment figures. Prospective buyers should therefore treat the robot's capabilities as validated in controlled demonstrations but not yet proven at scale across diverse customer sites, based solely on the information provided.
What it means for buyers
For organizations evaluating automation options in retail, logistics, and related sectors, the Galbot G1 represents an interesting data point in the evolving landscape of mobile manipulation. The robot's semi-humanoid form factor—wheels plus two arms—is a pragmatic middle ground between fixed automation and full humanoid robots. This design choice may offer advantages in facilities that are already designed for human movement, as wheeled platforms can navigate corridors and aisles effectively, while the two arms provide the dexterity needed for tasks like picking items from shelves, packing boxes, or restocking inventory.
The claim that the G1 can handle 5,000 different types of goods is a notable differentiator, if accurate. Many robotic systems in the market are limited to specific item categories or require extensive training for each new product. A system that can generalize across thousands of item types could reduce the integration effort and ongoing maintenance that buyers typically face when deploying automation in environments with high SKU counts. However, buyers should be cautious about the lack of independent verification of this figure. The source material does not provide a methodology for how this number was calculated, nor does it offer third-party validation. It is a company claim, and as with any vendor assertion, it should be tested in the buyer's own environment before commitment.
The involvement of CATL as a core strategic investor is another factor that buyers may want to consider. CATL is a major player in the battery industry, and its interest in Galbot could signal several things. First, it may indicate that CATL sees Galbot's technology as applicable to its own manufacturing and logistics operations, which could lead to large-scale deployments that help mature the product. Second, the collaboration on the general embodied intelligence large model suggests that the AI software powering the G1 is viewed as a platform with broader applications beyond the robot itself. For buyers, this could mean that Galbot's technology roadmap is well-funded and has the backing of a deep-pocketed strategic partner, which may reduce the risk of the company running out of capital before the product reaches maturity.
The total funding of approximately $335 million over two years provides Galbot with substantial resources to invest in product development, manufacturing scale-up, and go-to-market activities. For comparison, the source material notes that Unitree Robotics, another Chinese robotics company, recently raised Series C funding at a valuation of about $1.7 billion. While Galbot's valuation is not disclosed, the funding amounts suggest that the company is operating in the same league as other well-capitalized players in the Chinese robotics ecosystem. This financial backing may give buyers some confidence in the company's longevity and its ability to support its products over time, although the source does not provide any specific commitments regarding long-term support, software updates, or hardware warranties.
However, there are several unknowns that buyers should flag in their due diligence. The source does not disclose the G1's price, and without a price point, it is impossible to assess the total cost of ownership relative to manual labor or alternative automation solutions. There is also no information on the robot's operational specifications, such as battery life, payload capacity, speed, or uptime. These are critical parameters for any automation investment, and their absence from the public information means that buyers will need to request detailed specifications directly from Galbot.
Additionally, the source does not mention any existing customer references or case studies with quantified results. While the pharmacy demonstration shows that the robot can operate in a real-world environment, it does not provide evidence of long-term reliability, maintenance requirements, or the level of human oversight needed. Buyers in industries with high safety or regulatory requirements, such as pharmaceuticals or food handling, will need to ask specific questions about certifications, compliance, and fail-safe mechanisms. None of these details are available in the source material.
The geographic focus of Galbot's commercial efforts is also not specified. The company is based in Hangzhou, China, and its investors are predominantly Chinese institutions. It is possible that the initial commercial deployments will focus on the Chinese market, with international expansion to follow at a later date. Buyers outside of China should inquire about the company's plans for global availability, including local support infrastructure, regulatory approvals, and logistics for spare parts. The source does not provide any information on these topics, and no assumptions should be made.
In summary, the Galbot G1 is a promising development in the semi-humanoid robot category, backed by substantial funding and a strategic partnership with a major industrial player. The robot's ability to handle a wide range of goods and its wheeled, two-armed design make it a plausible candidate for automating inventory, replenishment, delivery, and packaging tasks. However, the public information available is limited to high-level claims and a single demonstration. Buyers should approach the product with a clear understanding of what is known—the funding, the product's existence, its intended use cases, and the claimed item-handling capability—and what is not known, including price, availability, specifications, and customer proof points. A thorough evaluation, including a pilot deployment in the buyer's own facility, would be the prudent next step before any large-scale commitment.
Sources
Published by Vigla Media OÜ (Estonia).